Hepatitis C Treatments in Current Clinical Development

Alan Franciscus
Editor-in-Chief

Updated January 21, 2012

PDF (download)

How to use the new HCV Advocate HCV Drug Pipeline:

• The first section is the Quick Reference Guide.  You can click on the label “Company” and it will link you directly to the company that is developing the drug.  Phase I studies will not include any additional information—except for DAAs.  Phase 2 and Phase 3 studies will include a short recap or comments of the clinical trial results.  You can access the comments by clicking on the “Drug Name.”
  
  
• The drugs that are being developed that are not DAA drugs can be accessed by clicking on the “Drugs in Development – General” link below this note.  We will not include comments in this section unless the drug has advanced into a Phase 3 or Phase 4 study.
  
  
• In addition we have various educational materials below to help explain some of the clinical trial processes and help with interpreting clinical trial data. 

Back to top

Back to Hepatitis C